These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 10950471

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Antipanic drug modulation of 35% CO2 hyperreactivity and short-term treatment outcome.
    Perna G, Bertani A, Caldirola D, Gabriele A, Cocchi S, Bellodi L.
    J Clin Psychopharmacol; 2002 Jun; 22(3):300-8. PubMed ID: 12006901
    [Abstract] [Full Text] [Related]

  • 3. Sertraline versus imipramine treatment of comorbid panic disorder and major depressive disorder.
    Lepola U, Arató M, Zhu Y, Austin C.
    J Clin Psychiatry; 2003 Jun; 64(6):654-62. PubMed ID: 12823079
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Imipramine vs. sertraline in panic disorder: 24-week treatment completers.
    Mavissakalian MR.
    Ann Clin Psychiatry; 2003 Jun; 15(3-4):171-80. PubMed ID: 14971862
    [Abstract] [Full Text] [Related]

  • 6. Modification of 35% carbon dioxide hypersensitivity across one week of treatment with clomipramine and fluvoxamine: a double-blind, randomized, placebo-controlled study.
    Perna G, Bertani A, Gabriele A, Politi E, Bellodi L.
    J Clin Psychopharmacol; 1997 Jun; 17(3):173-8. PubMed ID: 9169961
    [Abstract] [Full Text] [Related]

  • 7. Gender differences in treatment response to sertraline versus imipramine in chronic depression.
    Kornstein SG, Schatzberg AF, Thase ME, Yonkers KA, McCullough JP, Keitner GI, Gelenberg AJ, Davis SM, Harrison WM, Keller MB.
    Am J Psychiatry; 2000 Sep; 157(9):1445-52. PubMed ID: 10964861
    [Abstract] [Full Text] [Related]

  • 8. The effects of tianeptine or paroxetine on 35% CO2 provoked panic in panic disorder.
    Schruers K, Griez E.
    J Psychopharmacol; 2004 Dec; 18(4):553-8. PubMed ID: 15582922
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Switching from imipramine to sertraline in panic disorder.
    Mavissakalian MR.
    J Psychiatr Pract; 2004 Mar; 10(2):88-94. PubMed ID: 15330404
    [Abstract] [Full Text] [Related]

  • 12. Modulation of hyperreactivity to 35% CO2 after one week of treatment with paroxetine and reboxetine: a double-blind, randomized study.
    Perna G, Bertani A, Caldirola D, Di Pasquale D, Migliarese G, Bellodi L.
    J Clin Psychopharmacol; 2004 Jun; 24(3):277-82. PubMed ID: 15118481
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacologic effect of toloxatone on reactivity to the 35% carbon dioxide challenge: a single-blind, random, placebo-controlled study.
    Perna G, Cocchi S, Bertani A, Arancio C, Bellodi L.
    J Clin Psychopharmacol; 1994 Dec; 14(6):414-8. PubMed ID: 7884022
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Double-blind comparison of sertraline, imipramine, and placebo in the treatment of dysthymia: effects on personality.
    Hellerstein DJ, Kocsis JH, Chapman D, Stewart JW, Harrison W.
    Am J Psychiatry; 2000 Sep; 157(9):1436-44. PubMed ID: 10964860
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The use of newer antidepressants for panic disorder.
    Gorman JM.
    J Clin Psychiatry; 1997 Sep; 58 Suppl 14():54-8; discussion 59. PubMed ID: 9418747
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.